Discover open access scientific publications

Search, annotate, share and cite publications

Publications by OFRI MOSENZON

1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5

Internal Medicine

English

Related publications

983-P: Effect and Safety of Flexible Dose Adjustment With Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7

Internal Medicine

English

54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2

Internal Medicine

English

Linagliptin Added to Sulphonylurea in Uncontrolled Type 2 Diabetes Patients With Moderate-To-Severe Renal Impairment

Diabetes and Vascular Disease Research

Internal Medicine

Cardiovascular Medicine

English

Pleiotropic Effects of Liraglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment: Individual Effects of Treatment

Diabetes, Obesity and Metabolism

Internal Medicine

English

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context

Molecular Medicine

English

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment

Internal Medicine

Specialized Nursing

English

Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment

Diabetes Therapy

Internal Medicine

English

Association of Urinary Activity of MMP-9 With Renal Impairment in Mexican Patients With Type 2 Diabetes Mellitus

Molecular Biology

Biological Sciences

English

Oral Semaglutide in the Management of Type 2 Diabetes: A Report on the Evidence to Date

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English